MACD Oscillator Analysis for Editas Medicine Inc. (NASDAQ:EDIT)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Editas Medicine Inc. (NASDAQ:EDIT) for the period of 9-Day stands at 13.35% while the stochastic %D for the same period stands at 24.2%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Editas Medicine Inc. (NASDAQ:EDIT) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Editas Medicine Inc. (NASDAQ:EDIT) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Editas Medicine Inc. (NASDAQ:EDIT)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.

Previous Day Activity Analysis

On the last trading day, Editas Medicine Inc. (NASDAQ:EDIT) opened the session at $22.75 and after going up 1.8% closed at $23.2. The stock gained 0.45 points in the last trade.

Editas Medicine Inc. (NASDAQ:EDIT)’s stock fluctuated in the range of $22.70 and $23.93 during the previous active session. Editas Medicine Inc. (NASDAQ:EDIT) traded with the volume of 658196 with average volume of 1.18 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.51 and 52.55 respectively.

Currently the Insider Ownership of the shares of Editas Medicine Inc. (NASDAQ:EDIT) is at 3.5% and the shares outstanding are 44.45 Million.

Important Ratio Analysis

Some important ratios to consider here for Editas Medicine Inc. (NASDAQ:EDIT) are discussed below:

Dividend yield of Editas Medicine Inc. (NASDAQ:EDIT) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 184.15 and 5.12 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.18 and 95.49 correspondingly.

The Quick Ratio of Editas Medicine Inc. (NASDAQ:EDIT) stands at 6.7 while the Current Ratio depicts the value of 6.7.

Return on Assets ROA of Editas Medicine Inc. (NASDAQ:EDIT) is at -38.2% whereas, Return on Equity ROE and Return of Investment ROI of Editas Medicine Inc. (NASDAQ:EDIT) stand at -67.8% and -54.1% respectively.

Stock Performance Analysis

The stock performance of Editas Medicine Inc. (NASDAQ:EDIT) on the basis of 5 day trade show the dip of -7.97% whereas, the monthly performance of the stock shows increase of 8.56%.

The quarterly performance of the stock remained in green zone with the value of 46.19% while six month performance of the shares of Editas Medicine Inc. (NASDAQ:EDIT) remained bullish with the count of 20.52%.

The yearly and YTD performance of Editas Medicine Inc. (NASDAQ:EDIT) remained up at 74.96% and 42.95% respectively.